Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Comparison of the Inhibition Mechanisms of Adalimumab and Infliximab in Treating Tumor Necrosis Factor α-Associated Diseases from a Molecular View

Published:2013-09 Issue:38 Volume:288 Page:27059-27067
ISSN:0021-9258
Container-title:Journal of Biological Chemistry
language:en
Short-container-title:Journal of Biological Chemistry

Author:

Hu Shi,Liang Shuaiyi,Guo Huaizu,Zhang Dapeng,Li Hui,Wang Xiaoze,Yang Weili,Qian Weizhu,Hou Sheng,Wang Hao,Guo Yajun,Lou Zhiyong

Publisher

Elsevier BV

Subject

Cell Biology,Molecular Biology,Biochemistry

Reference38 articles.

1. Anti-TNF antibodies. Lessons from the past, roadmap for the future;Shealy;Handb. Exp. Pharmacol,2008

2. Anti-TNF-α therapies: the next generation;Palladino;Nat. Rev. Drug Discov,2003

3. Signalling pathways of the TNF superfamily. A double-edged sword;Aggarwal;Nat. Rev. Immunol,2003

4. The TNF superfamily in 2009. New pathways, new indications, and new drugs;Tansey;Drug Discov. Today,2009

5. Structural basis for treating tumor necrosis factor α (TNFα)-associated diseases with the therapeutic antibody Infliximab;Liang;J. Biol. Chem,2013

Cited by 124 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The structural basis for the selective antagonism of soluble TNF-alpha by shark variable new antigen receptors;2024-07-30

2. Anti-TNFα in inflammatory bowel disease: from originators to biosimilars;Frontiers in Pharmacology;2024-07-24

3. Thermostability and binding properties of single‐chained Fv fragments derived from therapeutic antibodies;Protein Science;2024-06-26

4. Modeling the subcutaneous pharmacokinetics of antibodies co‐administered with rHuPH20;Clinical and Translational Science;2024-04

5. Thermostability and binding properties of single-chained Fv fragments derived from therapeutic antibodies;2024-02-12

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3